Global Wearable Injectors Market Insights and Forecast to 2026

Published On: Aug 2020

Format: PDF

Publisher: QY Research

Pages: 148

Report ID: 228652

Wearable Injectors market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Wearable Injectors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Wearable Injectors market is segmented into
Electronical Injectors
Mechanical Injectors
Others

Segment by Application, the Wearable Injectors market is segmented into
Cancer
Infectious Disease
Autoimmune Disorder
Cardiovascular Disease
Blood Disorder
Others

Regional and Country-level Analysis
The Wearable Injectors market is analysed and market size information is provided by regions (countries).
The key regions covered in the Wearable Injectors market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Wearable Injectors Market Share Analysis

Wearable Injectors market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Wearable Injectors by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Wearable Injectors business, the date to enter into the Wearable Injectors market, Wearable Injectors product introduction, recent developments, etc.
The major vendors covered:
Becton
Dickinson and Company
Medtronic
Johnson & Johnson
Insulet Corporation
Unilife Corporation
Enable Injections
SteadyMed
Ypsomed Group
West Pharmaceutical Services
Unilife
CeQur
Sensile Medical
BD Medical
Roche
ScPharmaceuticals
SteadyMed
J & J

1 Study Coverage
1.1 Wearable Injectors Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Wearable Injectors Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Wearable Injectors Market Size Growth Rate by Type
1.4.2 Electronical Injectors
1.4.3 Mechanical Injectors
1.4.4 Others
1.5 Market by Application
1.5.1 Global Wearable Injectors Market Size Growth Rate by Application
1.5.2 Cancer
1.5.3 Infectious Disease
1.5.4 Autoimmune Disorder
1.5.5 Cardiovascular Disease
1.5.6 Blood Disorder
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Wearable Injectors Market Size, Estimates and Forecasts
2.1.1 Global Wearable Injectors Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Wearable Injectors Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Wearable Injectors Production Estimates and Forecasts 2015-2026
2.2 Global Wearable Injectors, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Wearable Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Wearable Injectors Manufacturers Geographical Distribution
2.4 Key Trends for Wearable Injectors Markets & Products
2.5 Primary Interviews with Key Wearable Injectors Players (Opinion Leaders)

3 Market Size by Manufacturers
3.1 Global Top Wearable Injectors Manufacturers by Production Capacity
3.1.1 Global Top Wearable Injectors Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Wearable Injectors Manufacturers by Production (2015-2020)
3.1.3 Global Top Wearable Injectors Manufacturers Market Share by Production
3.2 Global Top Wearable Injectors Manufacturers by Revenue
3.2.1 Global Top Wearable Injectors Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Wearable Injectors Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Wearable Injectors Revenue in 2019
3.3 Global Wearable Injectors Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans

4 Wearable Injectors Production by Regions
4.1 Global Wearable Injectors Historic Market Facts & Figures by Regions
4.1.1 Global Top Wearable Injectors Regions by Production (2015-2020)
4.1.2 Global Top Wearable Injectors Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Wearable Injectors Production (2015-2020)
4.2.2 North America Wearable Injectors Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Wearable Injectors Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Wearable Injectors Production (2015-2020)
4.3.2 Europe Wearable Injectors Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Wearable Injectors Import & Export (2015-2020)
4.4 China
4.4.1 China Wearable Injectors Production (2015-2020)
4.4.2 China Wearable Injectors Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Wearable Injectors Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Wearable Injectors Production (2015-2020)
4.5.2 Japan Wearable Injectors Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Wearable Injectors Import & Export (2015-2020)

5 Wearable Injectors Consumption by Region
5.1 Global Top Wearable Injectors Regions by Consumption
5.1.1 Global Top Wearable Injectors Regions by Consumption (2015-2020)
5.1.2 Global Top Wearable Injectors Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Wearable Injectors Consumption by Application
5.2.2 North America Wearable Injectors Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Wearable Injectors Consumption by Application
5.3.2 Europe Wearable Injectors Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Wearable Injectors Consumption by Application
5.4.2 Asia Pacific Wearable Injectors Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Wearable Injectors Consumption by Application
5.5.2 Central & South America Wearable Injectors Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Wearable Injectors Consumption by Application
5.6.2 Middle East and Africa Wearable Injectors Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E

6 Market Size by Type (2015-2026)
6.1 Global Wearable Injectors Market Size by Type (2015-2020)
6.1.1 Global Wearable Injectors Production by Type (2015-2020)
6.1.2 Global Wearable Injectors Revenue by Type (2015-2020)
6.1.3 Wearable Injectors Price by Type (2015-2020)
6.2 Global Wearable Injectors Market Forecast by Type (2021-2026)
6.2.1 Global Wearable Injectors Production Forecast by Type (2021-2026)
6.2.2 Global Wearable Injectors Revenue Forecast by Type (2021-2026)
6.2.3 Global Wearable Injectors Price Forecast by Type (2021-2026)
6.3 Global Wearable Injectors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)
7.2.1 Global Wearable Injectors Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Wearable Injectors Consumption Forecast by Application (2021-2026)

8 Corporate Profiles
8.1 Becton
8.1.1 Becton Corporation Information
8.1.2 Becton Overview
8.1.3 Becton Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Becton Product Description
8.1.5 Becton Related Developments
8.2 Dickinson and Company
8.2.1 Dickinson and Company Corporation Information
8.2.2 Dickinson and Company Overview
8.2.3 Dickinson and Company Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Dickinson and Company Product Description
8.2.5 Dickinson and Company Related Developments
8.3 Medtronic
8.3.1 Medtronic Corporation Information
8.3.2 Medtronic Overview
8.3.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Medtronic Product Description
8.3.5 Medtronic Related Developments
8.4 Johnson & Johnson
8.4.1 Johnson & Johnson Corporation Information
8.4.2 Johnson & Johnson Overview
8.4.3 Johnson & Johnson Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Johnson & Johnson Product Description
8.4.5 Johnson & Johnson Related Developments
8.5 Insulet Corporation
8.5.1 Insulet Corporation Corporation Information
8.5.2 Insulet Corporation Overview
8.5.3 Insulet Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Insulet Corporation Product Description
8.5.5 Insulet Corporation Related Developments
8.6 Unilife Corporation
8.6.1 Unilife Corporation Corporation Information
8.6.2 Unilife Corporation Overview
8.6.3 Unilife Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Unilife Corporation Product Description
8.6.5 Unilife Corporation Related Developments
8.7 Enable Injections
8.7.1 Enable Injections Corporation Information
8.7.2 Enable Injections Overview
8.7.3 Enable Injections Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Enable Injections Product Description
8.7.5 Enable Injections Related Developments
8.8 SteadyMed
8.8.1 SteadyMed Corporation Information
8.8.2 SteadyMed Overview
8.8.3 SteadyMed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 SteadyMed Product Description
8.8.5 SteadyMed Related Developments
8.9 Ypsomed Group
8.9.1 Ypsomed Group Corporation Information
8.9.2 Ypsomed Group Overview
8.9.3 Ypsomed Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Ypsomed Group Product Description
8.9.5 Ypsomed Group Related Developments
8.10 West Pharmaceutical Services
8.10.1 West Pharmaceutical Services Corporation Information
8.10.2 West Pharmaceutical Services Overview
8.10.3 West Pharmaceutical Services Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 West Pharmaceutical Services Product Description
8.10.5 West Pharmaceutical Services Related Developments
8.11 Unilife
8.11.1 Unilife Corporation Information
8.11.2 Unilife Overview
8.11.3 Unilife Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Unilife Product Description
8.11.5 Unilife Related Developments
8.12 CeQur
8.12.1 CeQur Corporation Information
8.12.2 CeQur Overview
8.12.3 CeQur Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 CeQur Product Description
8.12.5 CeQur Related Developments
8.13 Sensile Medical
8.13.1 Sensile Medical Corporation Information
8.13.2 Sensile Medical Overview
8.13.3 Sensile Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Sensile Medical Product Description
8.13.5 Sensile Medical Related Developments
8.14 BD Medical
8.14.1 BD Medical Corporation Information
8.14.2 BD Medical Overview
8.14.3 BD Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 BD Medical Product Description
8.14.5 BD Medical Related Developments
8.15 Roche
8.15.1 Roche Corporation Information
8.15.2 Roche Overview
8.15.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 Roche Product Description
8.15.5 Roche Related Developments
8.16 ScPharmaceuticals
8.16.1 ScPharmaceuticals Corporation Information
8.16.2 ScPharmaceuticals Overview
8.16.3 ScPharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.16.4 ScPharmaceuticals Product Description
8.16.5 ScPharmaceuticals Related Developments
8.17 SteadyMed
8.17.1 SteadyMed Corporation Information
8.17.2 SteadyMed Overview
8.17.3 SteadyMed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.17.4 SteadyMed Product Description
8.17.5 SteadyMed Related Developments
8.18 J & J
8.18.1 J & J Corporation Information
8.18.2 J & J Overview
8.18.3 J & J Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.18.4 J & J Product Description
8.18.5 J & J Related Developments

9 Wearable Injectors Production Forecast by Regions
9.1 Global Top Wearable Injectors Regions Forecast by Revenue (2021-2026)
9.2 Global Top Wearable Injectors Regions Forecast by Production (2021-2026)
9.3 Key Wearable Injectors Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan

10 Wearable Injectors Consumption Forecast by Region
10.1 Global Wearable Injectors Consumption Forecast by Region (2021-2026)
10.2 North America Wearable Injectors Consumption Forecast by Region (2021-2026)
10.3 Europe Wearable Injectors Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Wearable Injectors Consumption Forecast by Region (2021-2026)
10.5 Latin America Wearable Injectors Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Wearable Injectors Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Wearable Injectors Sales Channels
11.2.2 Wearable Injectors Distributors
11.3 Wearable Injectors Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Wearable Injectors Industry
12.2 Market Trends
12.3 Market Opportunities and Drivers
12.4 Market Challenges
12.5 Wearable Injectors Market Risks/Restraints
12.6 Porter's Five Forces Analysis
13 Key Finding in The Global Wearable Injectors Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer